Pharsight

Armstrong Pharms patents expiration

1. Primatene Mist patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8367734 ARMSTRONG PHARMS Stable epinephrine suspension formulation with high inhalation delivery efficiency
Jan, 2026

(2 years from now)

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 07 November, 2018

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

PRIMATENE MIST family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic